2-trifluoromethylnicotinamide derivatives as HDL-cholesterol raising agents

Details for Australian Patent Application No. 2009231375 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Roever, Stephan; Panousis, Constantinos G.; Hebeisen, Paul; Waldmeier, Pius; Wright, Matthew

Agent Spruson & Ferguson

Pub. Number AU-A-2009231375

PCT Pub. Number WO2009/121740

Priority 08153792.0 31.03.08 EP

Filing date 23 March 2009

Wipo publication date 8 October 2009

International Classifications

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/121740 Priority application(s): WO2009/121740

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009231376-3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDLcholesterol raising agents

2009231362-Detection and enumeration of microorganisms